{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:33:53Z","timestamp":1793054033842,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1472-6882-14-449","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T20:02:17Z","timestamp":1416340937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-\u03b1 induced hepatocyte apoptosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Yan-yan","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-chuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"issue":"6","key":"2067_CR1","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008, 134 (6): 1655-1669. 10.1053\/j.gastro.2008.03.003.","journal-title":"Gastroenterology"},{"issue":"2","key":"2067_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ncpgasthep0055","volume":"1","author":"SL Friedman","year":"2004","unstructured":"Friedman SL: Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol. 2004, 1 (2): 98-105. 10.1038\/ncpgasthep0055.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"1","key":"2067_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jhep.2009.03.024","volume":"51","author":"JX Jiang","year":"2009","unstructured":"Jiang JX, Mikami K, Venugopal S, Li Y, Torok NJ: Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK\/STAT and Akt\/NF-kappaB-dependent pathways. J Hepatol. 2009, 51 (1): 139-148. 10.1016\/j.jhep.2009.03.024.","journal-title":"J Hepatol"},{"issue":"5","key":"2067_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/hep.21867","volume":"46","author":"A Watanabe","year":"2007","unstructured":"Watanabe A, Hashmi A, Gomes DA, Town T, Badou A, Flavell RA, Mehal WZ: Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9. Hepatology. 2007, 46 (5): 1509-1518. 10.1002\/hep.21867.","journal-title":"Hepatology"},{"issue":"8","key":"2067_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman SL: Evolving challeges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010, 7 (8): 425-436. 10.1038\/nrgastro.2010.97.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"2067_CR6","doi-asserted-by":"publisher","first-page":"G709","DOI":"10.1152\/ajpgi.00451.2010","volume":"300","author":"JA Fallowfield","year":"2011","unstructured":"Fallowfield JA: Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011, 300 (5): G709-G715. 10.1152\/ajpgi.00451.2010.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"2067_CR7","first-page":"147","volume":"21","author":"B Du","year":"2001","unstructured":"Du B, You S: Present situation in preventing and treating liver fibrosis with TCM drugs. J Tradit Chin Med. 2001, 21 (2): 147-152.","journal-title":"J Tradit Chin Med"},{"issue":"2","key":"2067_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3736\/jcim20030218","volume":"1","author":"J Zhang","year":"2003","unstructured":"Zhang J, Xu L: [Advances of mechanism research on treatment of experimental liver fibrosis with traditional Chinese medicine]. Zhong Xi Yi Jie He Xue Bao. 2003, 1 (2): 142-145. 10.3736\/jcim20030218.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"2","key":"2067_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3736\/jcim20060221","volume":"4","author":"B Zhang","year":"2006","unstructured":"Zhang B, Wang LT: [Progress in experimental study on inhibitory effect of traditional Chinese medicine on liver fibrosis]. Zhong Xi Yi Jie He Xue Bao. 2006, 4 (2): 206-210. 10.3736\/jcim20060221.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"2","key":"2067_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jep.2013.05.031","volume":"148","author":"T Yang","year":"2013","unstructured":"Yang T, Shen DP, Wang QL, Tao YY, Liu CH: Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components. J Ethnopharmacol. 2013, 148 (2): 691-700. 10.1016\/j.jep.2013.05.031.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2067_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jep.2009.03.005","volume":"124","author":"KF Cheung","year":"2009","unstructured":"Cheung KF, Ye DW, Yang ZF, Lu L, Liu CH, Wang XL, Poon RT, Tong Y, Liu P, Chen YC, Lau GK: Therapeutic efficacy of Traditional Chinese Medicine 319 recipe on hepatic fibrosis induced by carbon tetrachloride in rats. J Ethnopharmacol. 2009, 124 (1): 142-150. 10.1016\/j.jep.2009.03.005.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"2067_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3736\/jcim20030204","volume":"1","author":"P Liu","year":"2003","unstructured":"Liu P, Hu YY, Liu C, Xu LM, Liu CH, Sun KW, Hu DC, Yin YK, Zhou XQ, Wan MB, Cai X, Zhang ZQ, Ye J, Tang BZ, He J: [Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]. Zhong Xi Yi Jie He Xue Bao. 2003, 1 (2): 89-98. 10.3736\/jcim20030204.","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"4","key":"2067_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3748\/wjg.v4.i4.348","volume":"4","author":"P Liu","year":"1998","unstructured":"Liu P, Liu C, Xu LM, Hu YY, Xue HM, Liu CH, Zhang ZQ: Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol. 1998, 4 (4): 348-353.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"2067_CR14","first-page":"459","volume":"16","author":"P Liu","year":"1996","unstructured":"Liu P, Liu C, Hu YY: [Effect of fuzheng huayu recipe in treating posthepatitic cirrhosis]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1996, 16 (8): 459-462.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1749-8546-4-12","volume":"4","author":"C Liu","year":"2009","unstructured":"Liu C, Hu Y, Xu L, Liu P: Effect of Fuzheng Huayu formula and its actions against liver fibrosis. Chin Med. 2009, 4: 12-22. 10.1186\/1749-8546-4-12.","journal-title":"Chin Med"},{"issue":"7","key":"2067_CR16","first-page":"412","volume":"19","author":"C Liu","year":"1999","unstructured":"Liu C, Wang X, Liu P: [Serapharmacological effect of fuzheng huayu 319 Decoction on expression of type I collagen and transforming growth factor beta 1 in hepatic stellate cells]. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999, 19 (7): 412-414.","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"5","key":"2067_CR17","first-page":"204","volume":"5","author":"T Zhou","year":"2008","unstructured":"Zhou T, Yan X, Chen Q, Tao Y, Liu C: [Effect of Fuzheng huayu decoction on hepatocytic apoptosis and necrosis on acute liver injury due to LPS in mice]. Drug Evaluation. 2008, 5 (5): 204-208.","journal-title":"Drug Evaluation"},{"issue":"1","key":"2067_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/hep.510310136","volume":"31","author":"EM Brunt","year":"2000","unstructured":"Brunt EM: Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000, 31 (1): 241-246. 10.1002\/hep.510310136.","journal-title":"Hepatology"},{"issue":"3","key":"2067_CR19","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1053\/j.gastro.2004.04.062","volume":"127","author":"R Safadi","year":"2004","unstructured":"Safadi R, Ohta M, Alvarez CE, Fiel MI, Bansal M, Mehal WZ, Friedman SL: Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes. Gastroenterology. 2004, 127 (3): 870-882. 10.1053\/j.gastro.2004.04.062.","journal-title":"Gastroenterology"},{"key":"2067_CR20","first-page":"972863","volume":"972863","author":"H Xie","year":"2013","unstructured":"Xie H, Tao Y, Lv J, Pinsaa L: Proteomic analysis of the effect of fuzheng huayu recipe on fibrotic liver in rats. Evid Based Complement Alternat Med. 2013, 972863: 972863-","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"2067_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-2697(81)90261-X","volume":"112","author":"IS Jamall","year":"1981","unstructured":"Jamall IS, Finelli VN, Que Hee SS: A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem. 1981, 112 (1): 70-75. 10.1016\/0003-2697(81)90261-X.","journal-title":"Anal Biochem"},{"issue":"5","key":"2067_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1258\/ebm.2009.009293","volume":"235","author":"X Yan","year":"2010","unstructured":"Yan X, Zhou T, Tao Y, Wang Q, Liu P, Liu C: Salvianolic acid B attenuates hepatocyte apoptosis by regulating mediators in death receptor and mitochondrial pathways. Exp Biol Med. 2010, 235 (5): 623-632. 10.1258\/ebm.2009.009293.","journal-title":"Exp Biol Med"},{"issue":"4","key":"2067_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ijc.20012","volume":"109","author":"T Kitamura","year":"2004","unstructured":"Kitamura T, Itoh M, Noda T, Matsuura M, Wakabayashi K: Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Int J Cancer. 2004, 109 (4): 576-580. 10.1002\/ijc.20012.","journal-title":"Int J Cancer"},{"issue":"5","key":"2067_CR24","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/hep.1840180533","volume":"18","author":"F Oberhammer","year":"1993","unstructured":"Oberhammer F, Bursch W, Tiefenbacher R, Froschl G, Pavelka M, Purchio T, Schulte-Hermann R: Apoptosis is induced by transforming growth factor-beta 1 within 5\u00a0hours in regressing liver without significant fragmentation of the DNA. Hepatology. 1993, 18 (5): 1238-1246. 10.1002\/hep.1840180533.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"2067_CR25","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1111\/j.1440-1746.2006.04645.x","volume":"22","author":"E Hatano","year":"2007","unstructured":"Hatano E: Tumor necrosis factor signaling in hepatocyte apoptosis. J Gastroenterol Hepatol. 2007, 22 (Suppl 1): S43-S44.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"2067_CR26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1172\/JCI9914","volume":"106","author":"ME Guicciardi","year":"2000","unstructured":"Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, Gores GJ: Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest. 2000, 106 (9): 1127-1137. 10.1172\/JCI9914.","journal-title":"J Clin Invest"},{"issue":"2","key":"2067_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2012.05.007","volume":"53","author":"JX Jiang","year":"2012","unstructured":"Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K, Brandes RP, Devaraj S, Torok NJ: Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4\/NOX1 inhibitor in vivo. Free Radic Biol Med. 2012, 53 (2): 289-296. 10.1016\/j.freeradbiomed.2012.05.007.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2067_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/hep.20051","volume":"39","author":"A Canbay","year":"2004","unstructured":"Canbay A, Friedman S, Gores GJ: Apoptosis: the nexus of liver injury and fibrosis. Hepatology. 2004, 39 (2): 273-278. 10.1002\/hep.20051.","journal-title":"Hepatology"},{"issue":"4","key":"2067_CR29","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.bbrc.2008.12.133","volume":"379","author":"TH Kim","year":"2009","unstructured":"Kim TH, Venugopal SK, Zhu M, Wang SS, Lau D, Lam KS, Clemens DL, Zern MA: A novel small molecule, LAS-0811, inhibits alcohol-induced apoptosis in VL-17A cells. Biochem Biophys Res Commun. 2009, 379 (4): 876-881. 10.1016\/j.bbrc.2008.12.133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2067_CR30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1124\/jpet.103.060129","volume":"308","author":"A Canbay","year":"2004","unstructured":"Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ: The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther. 2004, 308 (3): 1191-1196.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2067_CR31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1124\/jpet.103.062034","volume":"309","author":"NC Hoglen","year":"2004","unstructured":"Hoglen NC, Chen LS, Fisher CD, Hirakawa BP, Groessl T, Contreras PC: Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-te trafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor. J Pharmacol Exp Ther. 2004, 309 (2): 634-640. 10.1124\/jpet.103.062034.","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2067_CR32","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1210\/endo.137.5.8612529","volume":"137","author":"G Eghbali-Fatourechi","year":"1996","unstructured":"Eghbali-Fatourechi G, Sieck GC, Prakash YS, Maercklein P, Gores GJ, Fitzpatrick LA: Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis. Endocrinology. 1996, 137 (5): 1894-1903.","journal-title":"Endocrinology"},{"issue":"8","key":"2067_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/MEG.0b013e32831f1f3a","volume":"21","author":"M Galicia-Moreno","year":"2009","unstructured":"Galicia-Moreno M, Rodriguez-Rivera A, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P: N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur J Gastroenterol Hepatol. 2009, 21 (8): 908-914. 10.1097\/MEG.0b013e32831f1f3a.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2067_CR34","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/jcb.24609","volume":"114","author":"U Saini","year":"2013","unstructured":"Saini U, Gumina RJ, Wolfe B, Kuppusamy ML, Kuppusamy P, Boudoulas KD: Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation. J Cell Biochem. 2013, 114: 2612-2623. 10.1002\/jcb.24609.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2067_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0014-5793(97)00553-X","volume":"410","author":"D Wallach","year":"1997","unstructured":"Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W: Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett. 1997, 410 (1): 96-106. 10.1016\/S0014-5793(97)00553-X.","journal-title":"FEBS Lett"},{"issue":"2 Suppl 1","key":"2067_CR36","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1002\/hep.21062","volume":"43","author":"H Malhi","year":"2006","unstructured":"Malhi H, Gores GJ, Lemasters JJ: Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology. 2006, 43 (2 Suppl 1): S31-S44.","journal-title":"Hepatology"},{"issue":"53","key":"2067_CR37","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","volume":"22","author":"S Cory","year":"2003","unstructured":"Cory S, Huang DC, Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003, 22 (53): 8590-8607. 10.1038\/sj.onc.1207102.","journal-title":"Oncogene"},{"issue":"4","key":"2067_CR38","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2004.07.019","volume":"127","author":"T Takehara","year":"2004","unstructured":"Takehara T, Tatsumi T, Suzuki T, Rucker EB, Hennighausen L, Jinushi M, Miyagi T, Kanazawa Y, Hayashi N: Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology. 2004, 127 (4): 1189-1197. 10.1053\/j.gastro.2004.07.019.","journal-title":"Gastroenterology"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-14-449\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-14-449.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T07:04:48Z","timestamp":1630566288000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-14-449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-14-449","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]},"assertion":[{"value":"8 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"449"}}